![Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/064281c8-6e6b-438b-91fd-1139e1d974f4/gr1.gif)
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry
![Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study - The Lancet Psychiatry Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study - The Lancet Psychiatry](https://www.thelancet.com/cms/asset/00a9f86a-4183-4389-af48-164b1e702882/gr1.gif)
Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study - The Lancet Psychiatry
![Tardive Dyskinesia: Assessing and Treating a Debilitating Side Effect of Prolonged Antipsychotic Exposure | Psychiatric News Tardive Dyskinesia: Assessing and Treating a Debilitating Side Effect of Prolonged Antipsychotic Exposure | Psychiatric News](https://psychnews.psychiatryonline.org/cms/10.1176/appi.pn.2021.3.10/asset/images/medium/td_table1.jpg)
Tardive Dyskinesia: Assessing and Treating a Debilitating Side Effect of Prolonged Antipsychotic Exposure | Psychiatric News
![Long-Acting Injectable Antipsychotics for Schizophrenia: Why They Deserve Another Look - Psychiatry Advisor Long-Acting Injectable Antipsychotics for Schizophrenia: Why They Deserve Another Look - Psychiatry Advisor](https://www.psychiatryadvisor.com/wp-content/uploads/sites/8/2020/09/Das_Psych_CCH_How.to_.Treat_.Schizophrenia.Injectable.Antipsychotics-1-1024x1024.png)
Long-Acting Injectable Antipsychotics for Schizophrenia: Why They Deserve Another Look - Psychiatry Advisor
![Coming off antipsychotics may take years: first paper on how to withdraw | UCL News - UCL – University College London Coming off antipsychotics may take years: first paper on how to withdraw | UCL News - UCL – University College London](https://www.ucl.ac.uk/news/sites/news/files/pills_3.jpg)
Coming off antipsychotics may take years: first paper on how to withdraw | UCL News - UCL – University College London
![Long-Acting Injectable Antipsychotics for Schizophrenia: Why They Deserve Another Look - Psychiatry Advisor Long-Acting Injectable Antipsychotics for Schizophrenia: Why They Deserve Another Look - Psychiatry Advisor](https://www.psychiatryadvisor.com/wp-content/uploads/sites/8/2020/09/CCH_how-to-treat-schiz_hero.jpg)
Long-Acting Injectable Antipsychotics for Schizophrenia: Why They Deserve Another Look - Psychiatry Advisor
![When Should Antipsychotics for the Management of Behavioral and Psychological Symptoms of Dementia be Discontinued? When Should Antipsychotics for the Management of Behavioral and Psychological Symptoms of Dementia be Discontinued?](https://s3.amazonaws.com/HMP/hmp_ln/imported/inline-images/Screen%20Shot%202019-06-06%20at%2010.18.36%20AM.png)
When Should Antipsychotics for the Management of Behavioral and Psychological Symptoms of Dementia be Discontinued?
![Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse](https://psychscenehub.com/wp-content/uploads/2021/10/Symptoms-of-Antipsychotic-Withdrawal-Syndrome.png)
Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse
![To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial | Trials | Full Text To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-019-3822-5/MediaObjects/13063_2019_3822_Fig1_HTML.png)
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial | Trials | Full Text
![Long-acting injectable antipsychotics: a useful and well tolerated option in elderly patients with psychotic illnesses | SpringerLink Long-acting injectable antipsychotics: a useful and well tolerated option in elderly patients with psychotic illnesses | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.2165%2F00042310-200420120-00003/MediaObjects/40267_2012_20120007_Tab1.jpg)